Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsORALStandard

MATULANE

PROCARBAZINE HYDROCHLORIDE

Standard Dose
EQ 50MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription

Key Takeaways

  • Primary indication: Review priority: PRIORITY Marketing status: Prescription
  • Approval overview MATULANE is listed in Drugs@FDA under application 016785 (NDA).
  • Review priority: PRIORITY Marketing status: Prescription Active ingredient PROCARBAZINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 50MG BASE Sponsor LEADIANT BIOSCI INC Submission history Latest submission status date: 2016-02-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview MATULANE is listed in Drugs@FDA under application 016785 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient PROCARBAZINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 50MG BASE Sponsor LEADIANT BIOSCI INC Submission history Latest submission status date: 2016-02-02 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.